IDEAYA Biosciences Inc. (IDYA)
IDEAYA Biosciences Max Pain By Strike
IDYA trades at $24.33, 8.1% above the near-term max pain of $22.5 expiring Aug 15, 2025 (-1 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($12.5-$22.5), reflecting growing call interest at higher strikes. Key magnetic zone at 20 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
IDEAYA Biosciences Max Pain By Expiry
Max pain for IDYA shows an upward trend from 12.5 to 22.5, suggesting bullish positioning in longer-dated options. The 56% spread signals divergent expectations across timeframes. Most levels below 24.33 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 22.5 | -1.83 (-7.52%) |
| Sep 19, 2025 | 20 | -4.33 (-17.80%) |
| Oct 17, 2025 | 15 | -9.33 (-38.35%) |
| Jan 16, 2026 | 20 | -4.33 (-17.80%) |
| Apr 17, 2026 | 12.5 | -11.83 (-48.62%) |